Tech Company Financing Transactions
GigaMune Funding Round
GigaMune closed a investment round on 5/2/2019. Investors included private investors.
Transaction Overview
Company Name
Announced On
5/2/2019
Transaction Type
Debt
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company will use the proceeds to advance its research program in anti-tumor T cell receptor (TCR) discovery.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Tower Pl. 750
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
GigaMune was founded as a spin-out from GigaGen in 2017. We are combining unique insight into T cell responses to tumors with massively parallel T cell receptor (TCR) discovery to develop the next generation of T cell therapies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Johnson
VP - R & D
Matthew Spindler
Browse more venture capital transactions:
Prev: 5/2/2019: Aryaka venture capital transaction
Next: 5/2/2019: Forefront Telecare venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs